0001209191-19-010650.txt : 20190215 0001209191-19-010650.hdr.sgml : 20190215 20190215164215 ACCESSION NUMBER: 0001209191-19-010650 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190214 FILED AS OF DATE: 20190215 DATE AS OF CHANGE: 20190215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LUDLAM WILLIAM CENTRAL INDEX KEY: 0001736280 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37500 FILM NUMBER: 19612080 MAIL ADDRESS: STREET 1: C/O CHIASMA, INC. STREET 2: 460 TOTTEN POND ROAD, SUITE 530 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHIASMA, INC CENTRAL INDEX KEY: 0001339469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 460 TOTTEN POND ROAD STREET 2: SUITE 530 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-928-5300 MAIL ADDRESS: STREET 1: 460 TOTTEN POND ROAD STREET 2: SUITE 530 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: CHIASMA INC DATE OF NAME CHANGE: 20050922 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-14 0 0001339469 CHIASMA, INC CHMA 0001736280 LUDLAM WILLIAM C/O CHIASMA, INC. 460 TOTTEN POND ROAD SUITE 530 WALTHAM MA 02451 0 1 0 0 See Remarks Stock Option (Right to Buy) 3.75 2019-02-14 4 A 0 70000 0.00 A 2029-02-14 Common Stock 70000 70000 D The shares of Common Stock underlying the option will vest in quarterly installments over 4 years from the date of grant. : Title: Senior Vice President, Clinical and Medical Affairs /s/ Mark Fitzpatrick, Attorney-In-Fact 2019-02-15